Company Profiles

driven by the PitchBook Platform

Activate Immunotherapy

Activate Immunotherapy
1997 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$67.9M TOTAL AMOUNT RAISED
3 INVESTORS
Description

Operator of a clinical-stage immuno-oncology company. The company utilizes a novel approach for activating the body's immune system to recognize and destroy cancer cells.

Formerly Known As
NovaRx
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Biotechnology
Primary Office
8395 Camino Santa Fe Drive
Suite A
San Diego, CA 92121
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Activate Immunotherapy’s full profile, request a free trial.

Activate Immunotherapy Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 15-Aug-2016 $67.9M Completed Generating Revenue
8. Merger/Acquisition 02-May-2016 Cancelled Clinical Trials - Phase 3
7. Later Stage VC (Series C) 01-Sep-2014 0000 000.00 Completed Generating Revenue
6. Later Stage VC (Series D) 14-Mar-2007 0000 000.00 Completed Generating Revenue
5. Grant 01-Jan-2007 00.000 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 26-Aug-2005 000.00 000.00 Completed Generating Revenue
3. Grant 12-May-2004 00.000 Completed Generating Revenue
2. Grant 01-Jan-2003 $2.63M Completed Generating Revenue
1. Grant 09-Sep-2002 $2.95M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

Activate Immunotherapy Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Justin Murdock Angel (individual) Minority 000 0000 000000 0
Prescient Innovations I Other Minority 000 0000 000000 0
The O'Neal Company Corporation Minority 000 0000 000000 0

Activate Immunotherapy Executive Team (9)

Name Title Board
Seat
Contact
Info
Justin Murdock Chief Executive Officer & Executive Chairman
Todd Binder Chief Operating Officer
Habib Fakhrai Ph.D Co-Founder & Chief Scientific Officer
Feridoun Karimi-Busheri Ph.D Senior Investigator and Director of Stem Cell Department
Stella Sung Ph.D Chief Business Officer
You’re viewing 5 of 9 executives. Get the full list »

Activate Immunotherapy Board Members (1)

Name Representing Role Since Contact
Info
Justin Murdock Activate Immunotherapy Chief Executive Officer & Executive Chairman 000 0000